Sr. Manager, Regulatory CMC
VaxCyte
Summary
A hands-on role providing both strategic and operational activities. This role develops and executes multi-product global regulatory CMC strategies for investigational products and leads the preparation and filing of regulatory CMC submissions. Manages interactions with Health Authorities for CMC topics. Provides regulatory CMC guidance to various cross-functional teams and ensures all applicable global regulatory requirements are considered and incorporated into product development. Conducts routine regulatory surveillance and communicates new/changing regulations.
Job description
Summary
A hands-on role providing both strategic and operational activities. This role develops and executes multi-product global regulatory CMC strategies for investigational products and leads the preparation and filing of regulatory CMC submissions. Manages interactions with Health Authorities for CMC topics. Provides regulatory CMC guidance to various cross-functional teams and ensures all applicable global regulatory requirements are considered and incorporated into product development. Conducts routine regulatory surveillance and communicates new/changing regulations.
Essential Functions
- Represent Regulatory Affairs in various internal cross-functional project teams, improvement initiatives and providing regulatory positions on various CMC related topics.
- Manage the collection, review, coordination, and preparation of documentation for regulatory CMC submissions, including maintaining comprehensive trackers for documentation requests and timelines.
- Manage preparation of responses to queries from regulatory authorities.
- Ensure conformance to commitments made with various regulatory agencies.
- Collaborate with cross-functional project teams and external business partners to develop regulatory strategies and identify regulatory risks.
- Manage coordination, preparation, and timely submission of regulatory documents and filings.
- Review and approve change controls related to proposed product/process changes and assess their impact against regulatory requirements.
- Develop and execute regulatory CMC strategy for drug product (DP) and combination product/device presentations (e.g., prefilled syringes, autoinjectors), including container closure, formulation, fill/finish, and primary packaging considerations.
- Author, review, and coordinate drug product content for regulatory submissions (Module 3.2.P, device and combination product sections), including development, process validation, stability, container closure integrity, and extractables/leachables data.
- Assess changes to drug product manufacturing processes, sites, and device components for global regulatory impact, and define the filing strategy and reporting category for post-approval changes.
- Cultivate productive working relationships with the Regulatory team and other departments.
- Coordinate responses to CMC-related queries from Health Authorities.
- Stays abreast of current and evolving regulatory CMC requirements, applies this knowledge to assigned projects, and shares knowledge and experience with others to support their development.
Requirements
- Bachelor of Science in a scientific discipline (Biology, Chemistry, Pharmacy, Regulatory Affairs for Drugs, Biologics or Medical Devices).
- 9+ years of experience working in vaccine or biotech industry, or in a related field, or the equivalent combination of education and experience.
- Experience with drug product regulatory submissions, and working knowledge of combination product and device regulations (e.g., 21 CFR Part 4, EU MDR/Annex I GSPR requirements for integral devices, ISO 11608, design controls); drug-device combination experience is a plus.
- Prior experience preparing/authoring CMC DS sections: BLA highly preferred; Post-approval supplements/variations highly preferred; INDs/IMPDs.
- Prior development or manufacturing experience is a plus.
- Experience with module 3.2S and 3.2P.
- Computer software skills (LIMS, SAP, TrackWise, Veeva will be used).
- Ability to meet multiple deadlines across a variety of projects/programs, with a high degree of accuracy and efficiency.
- Applies in-depth understanding of how own discipline integrates within the function and understands contribution to Vaxcyte's achievement of business objectives.
Requirements
- Bachelor of Science in a scientific discipline (Biology, Chemistry, Pharmacy, Regulatory Affairs for Drugs, Biologics or Medical Devices)
- 9+ years of experience working in vaccine or biotech industry, or in a related field, or the equivalent combination of education and experience
- Experience with drug product regulatory submissions
- Working knowledge of combination product and device regulations (e.g., 21 CFR Part 4, EU MDR/Annex I GSPR requirements for integral devices, ISO 11608, design controls)
- Prior experience preparing/authoring CMC DS sections
- Experience with module 3.2S and 3.2P
- Computer software skills (LIMS, SAP, TrackWise, Veeva)
- Ability to meet multiple deadlines across a variety of projects/programs, with a high degree of accuracy and efficiency
- Applies in-depth understanding of how own discipline integrates within the function
Benefits
- Comprehensive benefits
- Equity component
Company overview
VaxCyte is a clinical-stage vaccine innovation company based in San Carlos, California, founded in 2013. The company specializes in engineering high-fidelity vaccines to protect against bacterial infectious diseases using advanced synthetic biology approaches. VaxCyte's proprietary cell-free protein synthesis platform enables rapid development and optimization of complex vaccines that are difficult to manufacture through conventional methods. The company's lead candidates include VAX-31, a 31-valent pneumococcal conjugate vaccine (PCV) currently advancing to Phase 3 clinical trials for adults and Phase 2 for infants, and VAX-24, a 24-valent PCV candidate. These vaccines are designed to provide broader protection against invasive pneumococcal disease compared to existing vaccines, covering more serotypes responsible for serious infections. VaxCyte's pipeline also includes early-stage programs targeting Group A Streptococcus, periodontitis, and Shigella. With approximately 414 employees and significant funding, including a recent $1.5 billion post-IPO equity round, VaxCyte is positioned as a leader in next-generation vaccine development, leveraging modern chemistry and synthetic techniques to address unmet medical needs in bacterial disease prevention.